Global Mitogen Activated Protein Kinase 14 Market Growth 2025-2031

October 2025 | 91 pages | ID: G5B161586043EN
LP Information

Abstracts

The global Mitogen Activated Protein Kinase 14 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Mitogen Activated Protein Kinase 14 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Mitogen Activated Protein Kinase 14 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Mitogen Activated Protein Kinase 14 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Mitogen Activated Protein Kinase 14 players cover Array BioPharma Inc., Astellas Pharma Inc., AstraZeneca Plc, Chiesi Farmaceutici SpA, Chroma Therapeutics Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Mitogen Activated Protein Kinase 14 Industry Forecast? looks at past sales and reviews total world Mitogen Activated Protein Kinase 14 sales in 2024, providing a comprehensive analysis by region and market sector of projected Mitogen Activated Protein Kinase 14 sales for 2025 through 2031. With Mitogen Activated Protein Kinase 14 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mitogen Activated Protein Kinase 14 industry.

This Insight Report provides a comprehensive analysis of the global Mitogen Activated Protein Kinase 14 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mitogen Activated Protein Kinase 14 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mitogen Activated Protein Kinase 14 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mitogen Activated Protein Kinase 14 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mitogen Activated Protein Kinase 14.

This report presents a comprehensive overview, market shares, and growth opportunities of Mitogen Activated Protein Kinase 14 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Ralimetinib Mesylate
• Losmapimod
• Neflamapimod
• CHF-6297
• Others

Segmentation by Application:

• Chronic Inflammation
• Ulcerative Colitis
• Epithelial Ovarian Cancer
• Gastric Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Array BioPharma Inc.
• Astellas Pharma Inc.
• AstraZeneca Plc
• Chiesi Farmaceutici SpA
• Chroma Therapeutics Limited
• Eli Lilly and Company
• GlaxoSmithKline Plc
• Synovo GmbH
• Toray Industries
• Zocere, Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Mitogen Activated Protein Kinase 14 market?
What factors are driving Mitogen Activated Protein Kinase 14 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mitogen Activated Protein Kinase 14 market opportunities vary by end market size?
How does Mitogen Activated Protein Kinase 14 break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mitogen Activated Protein Kinase 14 Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Mitogen Activated Protein Kinase 14 by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Mitogen Activated Protein Kinase 14 by Country/Region, 2020, 2024 & 2031
2.2 Mitogen Activated Protein Kinase 14 Segment by Type
  2.2.1 Ralimetinib Mesylate
  2.2.2 Losmapimod
  2.2.3 Neflamapimod
  2.2.4 CHF-6297
  2.2.5 Others
2.3 Mitogen Activated Protein Kinase 14 Sales by Type
  2.3.1 Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2020-2025)
  2.3.2 Global Mitogen Activated Protein Kinase 14 Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Mitogen Activated Protein Kinase 14 Sale Price by Type (2020-2025)
2.4 Mitogen Activated Protein Kinase 14 Segment by Application
  2.4.1 Chronic Inflammation
  2.4.2 Ulcerative Colitis
  2.4.3 Epithelial Ovarian Cancer
  2.4.4 Gastric Cancer
  2.4.5 Others
2.5 Mitogen Activated Protein Kinase 14 Sales by Application
  2.5.1 Global Mitogen Activated Protein Kinase 14 Sale Market Share by Application (2020-2025)
  2.5.2 Global Mitogen Activated Protein Kinase 14 Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Mitogen Activated Protein Kinase 14 Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Mitogen Activated Protein Kinase 14 Breakdown Data by Company
  3.1.1 Global Mitogen Activated Protein Kinase 14 Annual Sales by Company (2020-2025)
  3.1.2 Global Mitogen Activated Protein Kinase 14 Sales Market Share by Company (2020-2025)
3.2 Global Mitogen Activated Protein Kinase 14 Annual Revenue by Company (2020-2025)
  3.2.1 Global Mitogen Activated Protein Kinase 14 Revenue by Company (2020-2025)
  3.2.2 Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Company (2020-2025)
3.3 Global Mitogen Activated Protein Kinase 14 Sale Price by Company
3.4 Key Manufacturers Mitogen Activated Protein Kinase 14 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Mitogen Activated Protein Kinase 14 Product Location Distribution
  3.4.2 Players Mitogen Activated Protein Kinase 14 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MITOGEN ACTIVATED PROTEIN KINASE 14 BY GEOGRAPHIC REGION

4.1 World Historic Mitogen Activated Protein Kinase 14 Market Size by Geographic Region (2020-2025)
  4.1.1 Global Mitogen Activated Protein Kinase 14 Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Mitogen Activated Protein Kinase 14 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mitogen Activated Protein Kinase 14 Market Size by Country/Region (2020-2025)
  4.2.1 Global Mitogen Activated Protein Kinase 14 Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Mitogen Activated Protein Kinase 14 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mitogen Activated Protein Kinase 14 Sales Growth
4.4 APAC Mitogen Activated Protein Kinase 14 Sales Growth
4.5 Europe Mitogen Activated Protein Kinase 14 Sales Growth
4.6 Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Growth

5 AMERICAS

5.1 Americas Mitogen Activated Protein Kinase 14 Sales by Country
  5.1.1 Americas Mitogen Activated Protein Kinase 14 Sales by Country (2020-2025)
  5.1.2 Americas Mitogen Activated Protein Kinase 14 Revenue by Country (2020-2025)
5.2 Americas Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025)
5.3 Americas Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mitogen Activated Protein Kinase 14 Sales by Region
  6.1.1 APAC Mitogen Activated Protein Kinase 14 Sales by Region (2020-2025)
  6.1.2 APAC Mitogen Activated Protein Kinase 14 Revenue by Region (2020-2025)
6.2 APAC Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025)
6.3 APAC Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Mitogen Activated Protein Kinase 14 by Country
  7.1.1 Europe Mitogen Activated Protein Kinase 14 Sales by Country (2020-2025)
  7.1.2 Europe Mitogen Activated Protein Kinase 14 Revenue by Country (2020-2025)
7.2 Europe Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025)
7.3 Europe Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mitogen Activated Protein Kinase 14 by Country
  8.1.1 Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue by Country (2020-2025)
8.2 Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025)
8.3 Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mitogen Activated Protein Kinase 14
10.3 Manufacturing Process Analysis of Mitogen Activated Protein Kinase 14
10.4 Industry Chain Structure of Mitogen Activated Protein Kinase 14

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Mitogen Activated Protein Kinase 14 Distributors
11.3 Mitogen Activated Protein Kinase 14 Customer

12 WORLD FORECAST REVIEW FOR MITOGEN ACTIVATED PROTEIN KINASE 14 BY GEOGRAPHIC REGION

12.1 Global Mitogen Activated Protein Kinase 14 Market Size Forecast by Region
  12.1.1 Global Mitogen Activated Protein Kinase 14 Forecast by Region (2026-2031)
  12.1.2 Global Mitogen Activated Protein Kinase 14 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mitogen Activated Protein Kinase 14 Forecast by Type (2026-2031)
12.7 Global Mitogen Activated Protein Kinase 14 Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Array BioPharma Inc.
  13.1.1 Array BioPharma Inc. Company Information
  13.1.2 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.1.3 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Array BioPharma Inc. Main Business Overview
  13.1.5 Array BioPharma Inc. Latest Developments
13.2 Astellas Pharma Inc.
  13.2.1 Astellas Pharma Inc. Company Information
  13.2.2 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.2.3 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Astellas Pharma Inc. Main Business Overview
  13.2.5 Astellas Pharma Inc. Latest Developments
13.3 AstraZeneca Plc
  13.3.1 AstraZeneca Plc Company Information
  13.3.2 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.3.3 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 AstraZeneca Plc Main Business Overview
  13.3.5 AstraZeneca Plc Latest Developments
13.4 Chiesi Farmaceutici SpA
  13.4.1 Chiesi Farmaceutici SpA Company Information
  13.4.2 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.4.3 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Chiesi Farmaceutici SpA Main Business Overview
  13.4.5 Chiesi Farmaceutici SpA Latest Developments
13.5 Chroma Therapeutics Limited
  13.5.1 Chroma Therapeutics Limited Company Information
  13.5.2 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.5.3 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Chroma Therapeutics Limited Main Business Overview
  13.5.5 Chroma Therapeutics Limited Latest Developments
13.6 Eli Lilly and Company
  13.6.1 Eli Lilly and Company Company Information
  13.6.2 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.6.3 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Eli Lilly and Company Main Business Overview
  13.6.5 Eli Lilly and Company Latest Developments
13.7 GlaxoSmithKline Plc
  13.7.1 GlaxoSmithKline Plc Company Information
  13.7.2 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.7.3 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 GlaxoSmithKline Plc Main Business Overview
  13.7.5 GlaxoSmithKline Plc Latest Developments
13.8 Synovo GmbH
  13.8.1 Synovo GmbH Company Information
  13.8.2 Synovo GmbH Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.8.3 Synovo GmbH Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Synovo GmbH Main Business Overview
  13.8.5 Synovo GmbH Latest Developments
13.9 Toray Industries
  13.9.1 Toray Industries Company Information
  13.9.2 Toray Industries Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.9.3 Toray Industries Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Toray Industries Main Business Overview
  13.9.5 Toray Industries Latest Developments
13.10 Zocere, Inc.
  13.10.1 Zocere, Inc. Company Information
  13.10.2 Zocere, Inc. Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
  13.10.3 Zocere, Inc. Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Zocere, Inc. Main Business Overview
  13.10.5 Zocere, Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Mitogen Activated Protein Kinase 14 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mitogen Activated Protein Kinase 14 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ralimetinib Mesylate
Table 4. Major Players of Losmapimod
Table 5. Major Players of Neflamapimod
Table 6. Major Players of CHF-6297
Table 7. Major Players of Others
Table 8. Global Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2020-2025)
Table 10. Global Mitogen Activated Protein Kinase 14 Revenue by Type (2020-2025) & ($ million)
Table 11. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type (2020-2025)
Table 12. Global Mitogen Activated Protein Kinase 14 Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Mitogen Activated Protein Kinase 14 Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Mitogen Activated Protein Kinase 14 Sale Market Share by Application (2020-2025)
Table 15. Global Mitogen Activated Protein Kinase 14 Revenue by Application (2020-2025) & ($ million)
Table 16. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application (2020-2025)
Table 17. Global Mitogen Activated Protein Kinase 14 Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Mitogen Activated Protein Kinase 14 Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Company (2020-2025)
Table 20. Global Mitogen Activated Protein Kinase 14 Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Company (2020-2025)
Table 22. Global Mitogen Activated Protein Kinase 14 Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Mitogen Activated Protein Kinase 14 Producing Area Distribution and Sales Area
Table 24. Players Mitogen Activated Protein Kinase 14 Products Offered
Table 25. Mitogen Activated Protein Kinase 14 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Mitogen Activated Protein Kinase 14 Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Mitogen Activated Protein Kinase 14 Sales Market Share Geographic Region (2020-2025)
Table 30. Global Mitogen Activated Protein Kinase 14 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Mitogen Activated Protein Kinase 14 Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Country/Region (2020-2025)
Table 34. Global Mitogen Activated Protein Kinase 14 Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Mitogen Activated Protein Kinase 14 Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Mitogen Activated Protein Kinase 14 Sales Market Share by Country (2020-2025)
Table 38. Americas Mitogen Activated Protein Kinase 14 Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Mitogen Activated Protein Kinase 14 Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2020-2025)
Table 43. APAC Mitogen Activated Protein Kinase 14 Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Mitogen Activated Protein Kinase 14 Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Mitogen Activated Protein Kinase 14 Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Mitogen Activated Protein Kinase 14
Table 55. Key Market Challenges & Risks of Mitogen Activated Protein Kinase 14
Table 56. Key Industry Trends of Mitogen Activated Protein Kinase 14
Table 57. Mitogen Activated Protein Kinase 14 Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Mitogen Activated Protein Kinase 14 Distributors List
Table 60. Mitogen Activated Protein Kinase 14 Customer List
Table 61. Global Mitogen Activated Protein Kinase 14 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Mitogen Activated Protein Kinase 14 Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Mitogen Activated Protein Kinase 14 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Mitogen Activated Protein Kinase 14 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Mitogen Activated Protein Kinase 14 Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Mitogen Activated Protein Kinase 14 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Mitogen Activated Protein Kinase 14 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Mitogen Activated Protein Kinase 14 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Mitogen Activated Protein Kinase 14 Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Mitogen Activated Protein Kinase 14 Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Mitogen Activated Protein Kinase 14 Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Mitogen Activated Protein Kinase 14 Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Array BioPharma Inc. Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 76. Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 77. Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Array BioPharma Inc. Main Business
Table 79. Array BioPharma Inc. Latest Developments
Table 80. Astellas Pharma Inc. Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 81. Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 82. Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Astellas Pharma Inc. Main Business
Table 84. Astellas Pharma Inc. Latest Developments
Table 85. AstraZeneca Plc Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 87. AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. AstraZeneca Plc Main Business
Table 89. AstraZeneca Plc Latest Developments
Table 90. Chiesi Farmaceutici SpA Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 91. Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 92. Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Chiesi Farmaceutici SpA Main Business
Table 94. Chiesi Farmaceutici SpA Latest Developments
Table 95. Chroma Therapeutics Limited Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 96. Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 97. Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Chroma Therapeutics Limited Main Business
Table 99. Chroma Therapeutics Limited Latest Developments
Table 100. Eli Lilly and Company Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 101. Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 102. Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Eli Lilly and Company Main Business
Table 104. Eli Lilly and Company Latest Developments
Table 105. GlaxoSmithKline Plc Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 106. GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 107. GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline Plc Main Business
Table 109. GlaxoSmithKline Plc Latest Developments
Table 110. Synovo GmbH Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 111. Synovo GmbH Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 112. Synovo GmbH Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Synovo GmbH Main Business
Table 114. Synovo GmbH Latest Developments
Table 115. Toray Industries Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 116. Toray Industries Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 117. Toray Industries Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Toray Industries Main Business
Table 119. Toray Industries Latest Developments
Table 120. Zocere, Inc. Basic Information, Mitogen Activated Protein Kinase 14 Manufacturing Base, Sales Area and Its Competitors
Table 121. Zocere, Inc. Mitogen Activated Protein Kinase 14 Product Portfolios and Specifications
Table 122. Zocere, Inc. Mitogen Activated Protein Kinase 14 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Zocere, Inc. Main Business
Table 124. Zocere, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Mitogen Activated Protein Kinase 14
Figure 2. Mitogen Activated Protein Kinase 14 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mitogen Activated Protein Kinase 14 Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Mitogen Activated Protein Kinase 14 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mitogen Activated Protein Kinase 14 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mitogen Activated Protein Kinase 14 Sales Market Share by Country/Region (2024)
Figure 10. Mitogen Activated Protein Kinase 14 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ralimetinib Mesylate
Figure 12. Product Picture of Losmapimod
Figure 13. Product Picture of Neflamapimod
Figure 14. Product Picture of CHF-6297
Figure 15. Product Picture of Others
Figure 16. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type in 2025
Figure 17. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type (2020-2025)
Figure 18. Mitogen Activated Protein Kinase 14 Consumed in Chronic Inflammation
Figure 19. Global Mitogen Activated Protein Kinase 14 Market: Chronic Inflammation (2020-2025) & (K Pcs)
Figure 20. Mitogen Activated Protein Kinase 14 Consumed in Ulcerative Colitis
Figure 21. Global Mitogen Activated Protein Kinase 14 Market: Ulcerative Colitis (2020-2025) & (K Pcs)
Figure 22. Mitogen Activated Protein Kinase 14 Consumed in Epithelial Ovarian Cancer
Figure 23. Global Mitogen Activated Protein Kinase 14 Market: Epithelial Ovarian Cancer (2020-2025) & (K Pcs)
Figure 24. Mitogen Activated Protein Kinase 14 Consumed in Gastric Cancer
Figure 25. Global Mitogen Activated Protein Kinase 14 Market: Gastric Cancer (2020-2025) & (K Pcs)
Figure 26. Mitogen Activated Protein Kinase 14 Consumed in Others
Figure 27. Global Mitogen Activated Protein Kinase 14 Market: Others (2020-2025) & (K Pcs)
Figure 28. Global Mitogen Activated Protein Kinase 14 Sale Market Share by Application (2024)
Figure 29. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application in 2025
Figure 30. Mitogen Activated Protein Kinase 14 Sales by Company in 2025 (K Pcs)
Figure 31. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Company in 2025
Figure 32. Mitogen Activated Protein Kinase 14 Revenue by Company in 2025 ($ millions)
Figure 33. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Company in 2025
Figure 34. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Mitogen Activated Protein Kinase 14 Sales 2020-2025 (K Pcs)
Figure 37. Americas Mitogen Activated Protein Kinase 14 Revenue 2020-2025 ($ millions)
Figure 38. APAC Mitogen Activated Protein Kinase 14 Sales 2020-2025 (K Pcs)
Figure 39. APAC Mitogen Activated Protein Kinase 14 Revenue 2020-2025 ($ millions)
Figure 40. Europe Mitogen Activated Protein Kinase 14 Sales 2020-2025 (K Pcs)
Figure 41. Europe Mitogen Activated Protein Kinase 14 Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales 2020-2025 (K Pcs)
Figure 43. Middle East & Africa Mitogen Activated Protein Kinase 14 Revenue 2020-2025 ($ millions)
Figure 44. Americas Mitogen Activated Protein Kinase 14 Sales Market Share by Country in 2025
Figure 45. Americas Mitogen Activated Protein Kinase 14 Revenue Market Share by Country (2020-2025)
Figure 46. Americas Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2020-2025)
Figure 47. Americas Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2020-2025)
Figure 48. United States Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Mitogen Activated Protein Kinase 14 Sales Market Share by Region in 2025
Figure 53. APAC Mitogen Activated Protein Kinase 14 Revenue Market Share by Region (2020-2025)
Figure 54. APAC Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2020-2025)
Figure 55. APAC Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2020-2025)
Figure 56. China Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 60. India Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Mitogen Activated Protein Kinase 14 Sales Market Share by Country in 2025
Figure 64. Europe Mitogen Activated Protein Kinase 14 Revenue Market Share by Country (2020-2025)
Figure 65. Europe Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2020-2025)
Figure 66. Europe Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2020-2025)
Figure 67. Germany Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 68. France Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2020-2025)
Figure 75. Egypt Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Mitogen Activated Protein Kinase 14 Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Mitogen Activated Protein Kinase 14 in 2025
Figure 81. Manufacturing Process Analysis of Mitogen Activated Protein Kinase 14
Figure 82. Industry Chain Structure of Mitogen Activated Protein Kinase 14
Figure 83. Channels of Distribution
Figure 84. Global Mitogen Activated Protein Kinase 14 Sales Market Forecast by Region (2026-2031)
Figure 85. Global Mitogen Activated Protein Kinase 14 Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Mitogen Activated Protein Kinase 14 Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Mitogen Activated Protein Kinase 14 Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Mitogen Activated Protein Kinase 14 Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Mitogen Activated Protein Kinase 14 Revenue Market Share Forecast by Application (2026-2031)